<?xml version="1.0" encoding="UTF-8"?>
<p>In rat models, after the administration of tanshinone IIA, the growth of the ectopic endometrial tissue was significantly decreased, and the mechanical hyperalgesia was reduced. Moreover, the miRNA levels of angiotensinogen and angiotensin II were lowered in dorsal root ganglion neurons [
 <xref rid="B174-plants-10-00587" ref-type="bibr">174</xref>]. Tashinone IIA also increased the expression of Bax, a pro-apoptotic protein, and inhibited Bcl-xl and Bcl-2, two anti-apoptotic proteins [
 <xref rid="B175-plants-10-00587" ref-type="bibr">175</xref>]. Furthermore, this bioactive molecule demonstrated its antiangiogenic properties, by modulating VEGFA/HIF1-Î± signaling pathway and altering the MMP-2/TIMP-2 ratio in endothelial cells [
 <xref rid="B176-plants-10-00587" ref-type="bibr">176</xref>]. Tashinone I inhibited the formation of PGE2 from LPS-induced RAW macrophages, without affecting COX-2 expression and activity [
 <xref rid="B177-plants-10-00587" ref-type="bibr">177</xref>].
</p>
